Table 3 Joinpoint trends of gastric cancer incidence-based mortality rates, SEER-13, 1992–2018

Overall

1992–1994

35 (21.2 to 50.4)

 < 0.001

1994–2018

− 1.4 (− 1.6 to − 1.2)

 < 0.001

1992–2018

1 (0.2 to 1.8)*

0.008

Male

1992–1994

37.6 (24.9 to 51.5)

 < 0.001

1994–2018

− 1.6 (− 1.7 to − 1.4)

 < 0.001

1992–2018

1 (0.3 to 1.7)*

0.005

Female

1992–1994

40.3 (15 to 71.1)

0.002

1994–2018

− 1.1 (− 1.4 to − 0.8)

 < 0.001

1992–2018

1.6 (0.1 to 3.1)*

0.029

Age groups

 30–34

1992–2018

0.3 (− 1.0 to 1.6)

0.637

–

–

–

1992–2018

0.3 (− 1.0 to 1.6)

0.637

 35–39

1992–2018

1.5 (0.3 to 2.7)

0.015

–

–

–

1992–2018

1.5 (0.3 to 2.7)*

0.015

 40–44

1992–2018

0.5 (− 0.4 to 1.5)

0.260

–

–

–

1992–2018

0.5 (− 0.4 to 1.5)

0.260

 45–49

1992–2018

0.1 (− 0.8 to 1.1)

0.773

–

–

–

1992–2018

0.1 (− 0.8 to 1.1)

0.773

 50–54

1992–2018

− 0.5 (− 1.2 to 0.2)

0.181

–

–

–

1992–2018

− 0.5 (− 1.2 to 0.2)

0.181

 55–59

1992–1999

− 1.1 (− 1.9 to − 0.4)

0.005

1992–2018

− 1.1 (− 1.9 to − 0.4)*

0.005

 60–64

1992–1994

43.4 (14.5 to 79.8)

0.003

1994–2015

− 2.5 (− 2.9 to − 2.0)

 < 0.001

2015–2018

5.9 (− 2.3 to 14.9)

0.152

1992–2018

1.4 (− 0.5 to 3.4)

0.513

 65–69

1992–1994

43.5 (13.7 to 81.1)

0.004

1994–2018

− 2.1 (− 2.5 to − 1.7)

 < 0.001

1992–2018

0.8 (− 0.9 to 2.6)

0.325

 70–74

1992–1996

12.7 (5.8 to 20)

0.001

1996–2018

− 2.3 (− 2.8 to − 1.9)

 < 0.001

1992–2018

− 0.2 (− 1.1 to 0.8)

0.899

 75–79

1992–1994

41.6 (10.9 to 80.9)

0.007

1994–2018

− 1.6 (− 2.0 to − 1.2)

 < 0.001

1992–2018

1.2 (− 0.6 to 3)

0.188

 80–84

1992–1994

28.7 (12.3 to 47.5)

0.001

1994–1999

1.9 (− 1.4 to 5.2)

0.250

1999–2018

− 1.6 (− 1.9 to − 11.3)

 < 0.001

1992–2018

1.1 (− 0.0 to 2.3)

0.053